AgomAb Therapeutics welcomes Colin Bond to its Board as Independent Director
– BELGIUM, Ghent – AgomAb Therapeutics NV announced the appointment of Colin Bond to its Board as an Independent Non-Executive Director.…
– BELGIUM, Ghent – AgomAb Therapeutics NV announced the appointment of Colin Bond to its Board as an Independent Non-Executive Director.…
– BELGIUM, Ghent – MRM Health NV, a clinical-stage biopharmaceutical company developing innovative therapeutics for inflammatory, CNS, and metabolic diseases, announced the appointment of Dr.…
– BELGIUM, Ghent – Agomab Therapeutics NV today announced the appointment of David Epstein to its Board as a Non-Executive Director and Chairman.…
– BELGIUM, Ghent – Agomab Therapeutics NV, a company developing differentiated programs with disease-modifying potential in fibrotic diseases, today announced the appointment of Dr.…
– BELGIUM, Brussels – Confo Therapeutics, a leader in the discovery of medicines targeting G-protein coupled receptors, today announced the appointment of Dieter Weinand to its Board as Independent Chairman, bringing more than 35 years of experience in the pharmaceutical industry and over 25 years as the leader of geographic and strategic business units and drug commercialization efforts across global organizations.…